A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
Clinical trial NCT05028504 · UNKNOWN
Trial details
- NCT number
- NCT05028504
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2024-12-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.